ADDUS HOMECARE ($ADUS) is expected to release its quarterly earnings data on Monday, November 3rd after market close, per Finnhub. Analysts are expecting revenue of $361,558,012 and earnings of $1.56 per share.
You can see Quiver Quantitative's $ADUS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ADDUS HOMECARE Insider Trading Activity
ADDUS HOMECARE insiders have traded $ADUS stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $ADUS stock by insiders over the last 6 months:
- R DIRK ALLISON (Chairman and CEO) has made 0 purchases and 2 sales selling 25,000 shares for an estimated $2,873,850.
- W BRADLEY BICKHAM (President and COO) has made 0 purchases and 3 sales selling 13,000 shares for an estimated $1,501,100.
- BRIAN POFF (EVP, Chief Financial Officer) has made 0 purchases and 2 sales selling 7,739 shares for an estimated $904,087.
- DAVID W. TUCKER (EVP / Chief Strategy Officer) sold 2,403 shares for an estimated $277,378
- MICHAEL D. WATTENBARGER (EVP/Chief Information Officer) sold 2,045 shares for an estimated $235,175
- VERONICA HILL-MILBOURNE sold 1,571 shares for an estimated $180,555
- ESTEBAN LOPEZ sold 522 shares for an estimated $56,898
- ROBERTON JAMES STEVENSON (EVP & Chief HR Officer) sold 228 shares for an estimated $25,761
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ADDUS HOMECARE Hedge Fund Activity
We have seen 152 institutional investors add shares of ADDUS HOMECARE stock to their portfolio, and 146 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS added 567,907 shares (+106.3%) to their portfolio in Q2 2025, for an estimated $65,417,207
- PERRITT CAPITAL MANAGEMENT INC added 502,436 shares (+11419.0%) to their portfolio in Q2 2025, for an estimated $57,875,602
- WASATCH ADVISORS LP removed 316,381 shares (-25.4%) from their portfolio in Q2 2025, for an estimated $36,443,927
- POINT72 ASSET MANAGEMENT, L.P. added 231,076 shares (+76.5%) to their portfolio in Q2 2025, for an estimated $26,617,644
- TRIBUTARY CAPITAL MANAGEMENT, LLC added 212,192 shares (+114.1%) to their portfolio in Q3 2025, for an estimated $25,036,534
- MILLENNIUM MANAGEMENT LLC added 173,576 shares (+95.9%) to their portfolio in Q2 2025, for an estimated $19,994,219
- FMR LLC added 110,855 shares (+93.1%) to their portfolio in Q2 2025, for an estimated $12,769,387
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ADDUS HOMECARE Analyst Ratings
Wall Street analysts have issued reports on $ADUS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 09/02/2025
- Barclays issued a "Underweight" rating on 08/19/2025
- TD Cowen issued a "Buy" rating on 08/06/2025
- JMP Securities issued a "Market Outperform" rating on 07/16/2025
- Macquarie issued a "Outperform" rating on 06/10/2025
To track analyst ratings and price targets for ADDUS HOMECARE, check out Quiver Quantitative's $ADUS forecast page.
ADDUS HOMECARE Price Targets
Multiple analysts have issued price targets for $ADUS recently. We have seen 7 analysts offer price targets for $ADUS in the last 6 months, with a median target of $139.0.
Here are some recent targets:
- Raj Kumar from Stephens & Co. set a target price of $140.0 on 09/03/2025
- A.J. Rice from UBS set a target price of $145.0 on 09/02/2025
- Ben Hendrix from RBC Capital set a target price of $134.0 on 08/22/2025
- Andrew Mok from Barclays set a target price of $109.0 on 08/19/2025
- Ryan Langston from TD Cowen set a target price of $139.0 on 08/06/2025
- Constantine Davides from JMP Securities set a target price of $150.0 on 07/16/2025
- Tao Qiu from Macquarie set a target price of $133.0 on 06/10/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
